PHELIX THERAPEUTICS LLC
Philadelphia, United States · Founded 2015
- Headquarters
- Philadelphia, Pennsylvania
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
About
Phelix Therapeutics is a Philadelphia-based biopharmaceutical company developing calpain inhibitor therapies for fibrotic diseases, including idiopathic pulmonary fibrosis (IPF) and NASH. The company's approach targets myofibroblast generation to halt fibrotic progression, building on IP from Dr. Doron Greenbaum at the University of Pennsylvania. Phelix has received over $4.8M in NIH SBIR funding.
Summary
PHELIX THERAPEUTICS LLC is a Biotech company based in Philadelphia, United States, founded in 2015.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/phelix-therapeutics-llc"><img src="https://indexed.vc/api/badge/company/phelix-therapeutics-llc" alt="PHELIX THERAPEUTICS LLC on Indexed.vc" width="260" height="76" /></a>